2018
DOI: 10.1016/j.micpath.2017.11.067
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotics susceptibility of quinolones against Salmonella spp. strains isolated and molecularly sequenced for gyrA gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 30 publications
0
2
0
1
Order By: Relevance
“…Single point mutations in the quinolone resistance-determining region of gyrA reduce the sensitivity of fluoroquinolones (e.g., ciprofloxacin). However, antimicrobial resistance may require two or more mutations in the quinolone-determining region of gyrA, gyrB, parC, and parE [46][47][48]. Plasmids, transferred between different bacterial species and clones, can carry antimicrobial resistance or virulence genes.…”
Section: Discussionmentioning
confidence: 99%
“…Single point mutations in the quinolone resistance-determining region of gyrA reduce the sensitivity of fluoroquinolones (e.g., ciprofloxacin). However, antimicrobial resistance may require two or more mutations in the quinolone-determining region of gyrA, gyrB, parC, and parE [46][47][48]. Plasmids, transferred between different bacterial species and clones, can carry antimicrobial resistance or virulence genes.…”
Section: Discussionmentioning
confidence: 99%
“…A single substitution (T57S) was revealed in parC , whereas two different substitutions (S83E/Y and D124G/E) were reported in gyrA . In contrast, QRDR substitutions in gyrA of Salmonella isolates were reported to be S83F/Y and D87N in Mexico [31], S83F/I/T, D87N, H80N, and N78H in China [26], S83F and D87Y in Japan [32], and S83F and D87N in the USA [29]. T57S has been previously reported in isolates from Thailand, China, Korea, and Poland [22, 27, 33–35].…”
Section: Discussionmentioning
confidence: 99%
“…Las cepas de Salmonella pueden ganar resistencia a las quinolonas a través de una disminución de la expresión de las porinas y/o una mayor expresión de sistemas de expulsión no específicos, sistemas de expulsión energético-dependientes, tales como las bombas AcrAB-TolC. Sin embargo, estos mecanismos producen sólo un bajo nivel de resistencia a las quinolonas y son clínicamente importantes únicamente cuando concurren con alteraciones en las enzimas diana como la DNA girasa (Macías-Farrera et al, 2018).…”
Section: Resistencia a Las Quinolonas Y Fluoroquinolonasunclassified